Dr. Asma Deeb is a Consultant and Chief of Pediatric Endocrinology at Mafraq Hospital, Abu Dhabi. She trained in the UK since 1991. Dr. Deeb obtained an MD degree in Growth Hormone Gene Expression in 2002 from University of Newcastle. She was appointed as a Clinical Lecturer in Pediatric Endocrinology at the University of Cambridge between 2001 and 2005 and obtained a CCST in Paediatric Endocrinology. Dr. Deeb has special interest in disorders of sexual differentiation, use of technology in management of children with diabetes and genetics of diabetes mellitus in which she has published in Peer Review Journals.
Dr Asma Binjab is a Canadian board certified pediatric Endocrinologist and Diabetologist, she has wide experience in managing various Endocrine disorders in children and adolescents like short stature, tall stature, thyroid problems, puberty disorders,adrenal insufficiency ,disorders of sexual differentiation, .etc. In the field of Diabetes, she treats all types of Diabetes in children and adolescents, also fully experienced in the use of advance technology (insulin pumps, continuous glucose monitoring sensor, etc.)In management of diabetes.
Dr. Elham Mohamed Al Amiri is a prominent consultant pediatrician and a renowned academic in the UAE. Dr. Al Amiri received her medical degree from King Faisal University in Saudi Arabia in 1993, and then she obtained her Master's degree in Pediatrics from Trinity College at the University of Dublin (Ireland). She is currently an adjunct assistant professor at the college of medicine, University of Sharjah, and a consultant pediatrician at Al Qassimi Hospital in Sharjah, where she is also the head of the Diabetes and Endocrine Unit.
Throughout her career, Dr. Al Amiri had worked with numerous distinguished hospitals such as Al Ain Hospital, Latifa Hospital and Rashid Hospital before joining Al Qassimi Hospital in Sharjah. Additionally, she was a pediatric endocrinology fellow at King Faisal Specialist Hospital and Research center in Saudi Arabia and an ESPE Clinical fellow at the Royal Manchester Children's Hospital in the UK.
Consultant Endocrinologist & the Head of the Endocrine Department-Dubai Hospital.
Chairperson of Diabetes Combat and Control Committee - DHA
Member of National Diabetes Committee
General Secretary of EDS
Senior Lecturer at Dubai Medical College
Host examiner for MRCP, PACES exam.
Actively involved in various studies in diabetes and endocrinology with several publications.
Dr.Hassanein is a senior consultant in Endocrinology and Diabetes at Dubai Hospital, Dubai, UAE since 2014. He holds an Academic post of Senior Lecturer, and Associate Director for Postgraduate Diabetes Education, Cardiff University. UK since 2007. Dr Hassanein is the Chair of the scientific committee of the Arab Association for the Study of Diabetes and founding member in the Arab Diabetes Consensus Group. He is also Royal College of Physician's examiner for the PACES section of the exam. As part of a higher degree program with the Human Nutrition Unit of Reading University in conjunction with the Diabetes Centre of the Royal Berkshire Hospital. Dr Hassanein conducted five important clinical trials. Three of these trials are to assess the effect of zinc and chromium supplementation to the glycaemic control, lipids profile and manifestations of the metabolic syndrome of people with type 2 diabetes. Dr Hassanein has been principle and co-investigator in several landmark clinical trials and have number of publications related to the field of Diabetes.
Dr. Ehtisham graduated from the University of Cambridge in the UK and conducted her clinical training at Addenbrooke's Hospital. She is an exceptionally experienced paediatric endocrinologist who has received many research awards for her investigations into childhood diabetes.
Prior to joining Mediclinic City Hospital, she was clinical lead for diabetes at the Royal Manchester Children's Hospital and she was also an honorary lecturer in Endocrinology at the University of Manchester.
Dr. Ehtisham received her CCST in Paediatric Endocrinology in 2007. She was also a member of the Royal College of Physicians Working Party on Obesity which published its report in 2013 and is part of the All Party Parliamentary Group on Obesity which meets regularly at the House of Commons in the UK.
is Professor and Head of Paediatrics at the Department of Paediatrics, University of Chieti in Chieti, Italy. He is also Head of Research Labs for Experimental Medicine in Pediatrics and Child Health. He received his undergraduate education at the University of Siena, Italy.
Francesco Chiarelli's research interests include the molecular and cellular biology of diabetic macroangiopathy; insulin resistance in children; early detection of diabetic microangiopathy in children; obesity and type 2 diabetes in children, growth and puberty disorders.
He has written extensively and published in leading scientific journals such as The Lancet, New England Journal of Medicine, Journal of Clinical Endocrinology and Metabolism, Diabetes, Diabetes Care, Diabetologia, Clinical Endocrinology, Circulation, ATVB (629 papers; Impact Factor 3,056; Citation Index: 11,324; h-index 57). He is (or has been) on the Editorial Board of Journal of Pediatric Endocrinology and Metabolism, Pediatric Diabetes, Hormone Research, Diabetes, Nutrition and Metabolism. He has also been an invited lecturer throughout Europe, Japan, Australia, Africa and South and North America.
Francesco Chiarelli holds membership in several professional organizations, including the European Society of Paediatric Endocrinology (ESPE), the International Society for Pediatric and Adolescent Diabetes (ISPAD)(Member of the Advisory Council 1990-1993, Chair of Scientific Committee 2001-2004), the American Diabetes Association (ADA), the International Pediatric Association (IPA), the Italian Society for Pediatric Endocrinology and Diabetology (ISPED)(Member of the Advisory Council 1990-1996). He was ESPE Secretary General (2004-2011) and ESPE President (2008-2009 and 2012-2013). He was President of the Italian Society for Paediatric Research (ISPR)(2012-2015) and Member of the WHO Task Force for Childhood Diabetes. He is currently a Consultant of the European Commission and of the WHO for Non-Communicable Diseases (NCD) in Children.
Jennifer A. Sipos is a Professor of Medicine and Director of the Benign Thyroid Disorders Program at The Ohio State University. She obtained her medical degree and received her Internal Medicine residency training at Wake Forest University. She completed her Endocrinology and Metabolism fellowship at the University of North Carolina in Chapel Hill. Dr. Sipos has developed an interest in the use of ultrasonography for the diagnosis and management of thyroid cancer and has taught and served as a course director for numerous ultrasound courses nationally and internationally, including meetings for the Endocrine Society, American Thyroid Association, European Thyroid Association, American Association for Clinical Endocrinologists, Asia and Oceania Thyroid Association, Indian Endocrine Society, and International Congress for Endocrinology. Additionally, she is actively involved in several clinical research projects with a particular interest in factors implicated in the development of salivary damage after radioiodine therapy. She also participates in clinical trials for the evaluation of multikinase inhibitor therapies in refractory thyroid cancer and the diagnostic use of molecular markers in thyroid nodules. She has received numerous patient care awards, including America's Best Doctors, Castle Connelly's Top Doctors in Endocrinology, and Top 10% Nationally for Patient Satisfaction Scores. Further, she serves as an invited member of the writing task force for the Thyroidectomy Guidelines of the American Association of Endocrine Surgeons which is scheduled to be published in 2018.
John Wass is the Professor of Endocrinology at Oxford University and was Head of the Department of Endocrinology at the Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital Oxford, UK until 2012.
His research interests include all pituitary tumours, especially acromegaly, adrenal disease, angiogenesis in endocrinology, and the genetics of osteoporosis and thyroid disease.
Since 1975 he has published over 385 articles in scientific journals and as well as written many reviews and chapters in textbooks including the Oxford Textbook of Medicine and DeGroot's Textbook of Endocrinology. He has also edited a number of different textbooks including the Oxford Textbook of Endocrinology, Clinical Endocrine Oncology and the Oxford Handbook of Endocrinology (3 editions). He was President of the European Federation of Endocrine Societies from 2001-2003 and was Chairman of the Society for Endocrinology (2006-2009. He has also served as President of the Pituitary Society.
This year he received the Lifetime Achievement Award by the Pituitary Society in the USA
He has won a number of prizes and given named lectures including the Jubilee Prize of the Society for Endocrinology. He was recently in June 2015 awarded the Distinguished Physician of the Year Award by the American Endocrine Society; the first non American to ever receive this award.
Amongst his charitable activities, he is Patron of the St. Pauls Way School (with Professor Brian Cox) and he founded the Pituitary Foundation.
He was Academic Vice President of the Royal College of Physicians in London, from August 2012 until August 2015.
He chaired the Royal College of Physicians Working Party 'Action on Obesity: Comprehensive Care for All' published in January 2013, and has been involved improving services for patients with obesity.
Recently he presented the acclaimed documentary 'The Fantastical World of Hormones' on BBC4.
Professor Robert McLachlan is a physician-scientist and Principal Research Fellow with a programme of basic and clinical research in male reproductive health. He joined the Prince Henry's Institute, now Hudson Institute of Medical Research, in 1983.
Prof McLachlan has made major contributions to scientific discovery, translation into clinical practice and education in male reproductive health. His particular interests are male fertility regulation, the genetics of male infertility and androgen physiology.
He is Deputy Director of Endocrinology at Monash Medical Centre, Consultant Andrologist to the Monash IVF program, consultant to the WHO and is the Director of Andrology Australia, a Federal Government initiative committed to research and community & professional education in male reproductive health.
Prof McLachlan has a strong track record of basic, clinical and translational research into male contraception, androgen physiology and male infertility, including its genetics and its management by assisted reproduction. His research program has been supported by continuous NHMRC funding for past 25 years and, in addition, through other peer reviewed and industry-funded sources.
Prof McLachlan has a long history of linking basic research on male fertility regulation to clinical outcomes. This research has consistently extended results from animal models into studies in man, resulting in major contributions to methods of evaluating spermatogenesis, its endocrine regulation and to developing male hormonal contraception. A major area of research is translational studies in male infertility, which is undertaken in collaboration with colleagues at Monash University and The University of Newcastle. As an Associate of the Hudson Instituteís Centre for Reproductive Health, Prof McLachlan also has a long standing research interest in the regulation of spermatogenesis.
Prof McLachlan is a leading advocate for menís health on the national stage. As Director of Andrology Australia, he co-ordinates research into menís reproductive health and aims to raise awareness of male reproductive health disorders and their associations with chronic disease. He also contributes to the research and education on men's health and fertility through membership of the World Health Organisation subcommittee for Research on Methods for the Regulation of Male Fertility and as a member of various peak bodies such as the Fertility Society of Australia and the International Society of Andrology.
Research on androgen physiology and therapy in ageing and metabolic disease is also a major focus of Prof McLachlan, with several clinical interventional studies investigating a range of endpoints including quality of life, body composition and cardiovascular risk. These studies include participation in the major multicentre 'T4DM' RCT of testosterone in obese men with pre- or early type 2 diabetes.
Prof McLachlan has been a consultant Andrologist at Monash IVF since 1991, and has a long standing interest in advocacy and research aimed at improving ART (assisted reproduction technologies) outcomes through his Chairmanship of the Monash IVF Research and Education Foundation and collaborative research with scientists and clinicians in the Monash IVF and Repromed programs, and the University of Adelaide.
Professor McLachlanís expertise lies in clinical research, andrology, endocrinology, testosterone, infertility, spermatogenesis, androgens, assisted reproduction and health promotion and policy.
Andrew Narva, MD, is the director of the National Kidney Disease Education Program at the National Institutes of Health. Prior to joining the NKDEP in 2006, he served as chief clinical consultant for nephrology and director of the Kidney Disease Program for the Indian Health Service. He has served as a member of the Medical Review Board of ESRD Network 15, on the NKF KDOQI Work Group on Diabetes in Chronic Kidney Disease, as a member of the JNC 8 Expert Panel and as a member of Working Group on CKD, International Federation of Clinical Chemistry and Laboratory Medicine. He serves on the Nephrology Subspecialty Board of the American Board of internal Medicine. In 2002 Dr. Narva was recognized by the IHS National Council of Clinical Directors as Physician Leader of the Year and by the US Public Health Service as the Clinical Physician of the Year. In 2003 he received the USPHS Distinguished Service Medal, the highest recognition awarded to commissioned officers. Dr. Narva received the 2015 Nostradamus Award from the Council of Advanced Practitioners of the National Kidney Foundation. Although Dr. Narva now works at NIH, he continues to serve as the Chief Clinical Consultant for Nephrology for IHS and continues to provide care for patients at Zuni Pueblo through a telemedicine clinic and at Walter Reed National Military Medical Center.
Dr. Cornier has been on faculty at the University of Colorado with the Division of Endocrinology, Metabolism and Diabetes since 2001, where he is currently a Professor of Medicine. Prior to that he received his undergraduate education at Vanderbilt University in Biomedical Engineering. He then attended the Medical College of Georgia where he received his medical degree. He went on to do his medical residency at Georgetown University Medical Center and followed this with a fellowship in endocrinology at the University of Colorado Health Sciences Center. Dr. Cornier is currently the Medical Director of the Anschutz Health and Wellness Center, Medical Director of the My New Weigh meal-replacement weight loss program at the health and wellness center, Director of the LDL Apheresis Program at University of Colorado Hospital, and staff endocrinologist/diabetologist/lipidologist at the University of Colorado Hospital. Dr Cornier is an active clinical and translational investigator with a primary research interest in understanding the complex regulation of food intake and body weight and metabolism. Dr Cornier has been a very active volunteer in important health-related associations, such as the Endocrine Society, Obesity Society, American Diabetes Association, and American Heart Association.
Dr. Cornier has been on faculty at the University of Colorado with the Division of Endocrinology, Metabolism and Diabetes since 2001. Prior to that he received his undergraduate education at Vanderbilt University in Nashville, TN where he received a bachelor of science in Biomedical Engineering in 1987. He then attended the Medical College of Georgia in Augusta, GA where he received his medical degree in 1992. He went on to do his medical internship and residency at Georgetown University Medical Center in Washington, DC with the Department of Internal Medicine from 1992 to 1995. He followed this with a fellowship in endocrinology at the University of Colorado Health Sciences Center in Denver, CO which he completed in 1999. Dr Cornier is an active clinical and translational investigator with a primary interest in understanding the complex regulation of food intake and body weight. He is a member of the Anschutz Health and Wellness Center. Dr. Cornier has also been on staff at Denver Health Medical Center in Denver, CO since 1999 as a clinical endocrinologist and educator. He was also the medical director of the Exempla Lutheran Diabetes Center from 2002-2008. Dr Cornier has been an active volunteer in important health-related associations, such as the American Diabetes Association, American Heart Association, the Endocrine Society and the Obesity Society.
Dr. Stanley Schwartz is an Affiliate of the Main Line Health System, and an Emeritus Associate Professor of Medicine at the University of Pennsylvania, currently in a private practice in Ardmore, Pa. Dr. Schwartz received his MD in 1973 from the University of Chicago in Chicago, Illinois. He then completed his residency at the University of Pennsylvania, followed by a fellowship in endocrinology and metabolism at the University of Chicago.
Dr. Schwartz actively lectures nationally, as well as internationally, about diabetes and its treatment. In the past 6 years he has been a CME speaker in Turks/Caicos, Istanbul, Switzerland , Belgium, Tunisia ,Spain , 11 cities in China, Phillipines x3 (AACE, Phillipine Endo. Societyx2), Singapore, Korea , and Ireland, and AACE 2011/2014, ADA 2014-2015. He has authored numerous articles in peer-reviewed scientific journals and has been a lead or co-investigator for many clinical trials (DCCT-EDIC, LOOK AHEAD). He has created a call for minimizing hypoglycemia ( predicting a ~50% in hospitals using incretins, and minimizing insulin use in 'Type 2 ' DM. He has proposed a New Classification and Unified Pathophysiologic Construct for All Diabetes and presented it in Jerusalem, at ADA 2014 and ADA/JDRF symposium 2015 and now published in Diabetes Care, and Trends in Endocrinology.
Since leaving Penn, he has received an R-01 from the NIH for studying the Genes related to LADA (with 2 articles published), written 3 book chapters, had posters at 2012 AACE, ADA and EASD in 2014 and 2015), has had 28 peer-reviewed article's published (incretins in Hospital , hypoglycemia, a critique of ADA DM guideline , incretins in NODAT , weight reduction in DM, the incretin story), and most recently A Unified Pathophysiologic Construct of DM and its Complications.. He is an author of the Self-Assessment Program of the American Diabetes Assoc (2007 and 2008) , the 2009/2010 AACE Diabetes Guidelines, and slide modules for primary care for AACE, 2011 and 2013, and Diabetes in Control 2013-2017 . He is a member or fellow of international, national, and local professional societies including an Overseas Fellow of the Royal Society of Medicine (London), European Association for the Study of Diabetes (EASD), the International Diabetes Federation (IDF), the American Diabetes Association (ADA), the American Endocrine Society (ES), College of Physicians in Philadelphia, and the American College of Physicians (ACP). He's been elected by his peers for inclusion in Best Doctors in America® from 1996 to 2017. Though he does some research and teaches a great deal, most of his time is spent caring for patients .
Prof. Sunder Mudaliar trained in India, England and the United States and is currently a Board-Certified Endocrinologist. His present appointments include Clinical Professor of Medicine at the University of California in San Diego and Director of the Diabetes Clinic at the VA San Diego Healthcare System. He has focused his research on the clinical aspects of diabetes and its treatment and is an Investigator in several landmark studies. These include the NIH-sponsored Diabetes Prevention Program Outcomes Study; the NIH-DCCT/EDIC Study which is the long-term observational follow-up of the cohort originally recruited into the original Diabetes Control and Complications Trial; and the NIH-GRADE study which is evaluating which medication is cost-effective after metformin in patients with type 2 diabetes. Dr. Mudaliar is active in seeing patients and teaching and has published more than 180 original articles in peer-reviewed journals (including the New England Journal of Medicine and Lancet) and has written 40 book chapters and Invited Reviews.
Dr. Richard Santen is a professor of medicine at the University of Virginia. His research interests have focused on the development of aromatase inhibitors for treatment of breast cancer, mechanisms relating estrogens to breast cancer and the biology and natural history of endocrine-dependent breast cancer. He has published over 400 manuscripts and chapters, predominantly related to the role of estrogen in breast cancer development and treatment. For his work in the development of aromatase inhibitors, he received the Susan Komen Foundation Brinker International Award for breast cancer clinical research in 1993. Other awards include the Clinical Chemistry Distinguished Science Award, the Robert H. Williams Distinguished Leadership Award of the Endocrine Society, and the William L. McGuire Memorial Lectureship Award for breast cancer. He is the president-elect of the Endocrine Society for 2013 and president for 2014.
Dr. Al Jubeh is the Chairman of Pediatrics at Sheikh Khalifa Medical City in Abu Dhabi, UAE. He is a consultant pediatric endocrinologist at SKMC since 2006. He graduated from the medical school at the University of Jordan then completed his training in pediatrics and pediatric endocrinology at the University of Texas Medical Branch in Galveston, Texas, USA. He is American Board certified in pediatrics and pediatric endocrinology. He worked as a consultant pediatric endocrinologist at Saudi Aramco Dhahran medical center until 2006. He has several publications in peer reviewed journals and many presentations in regional meetings. He is core faculty in the pediatric residency program at SKMC and member of several societies in the field of pediatric endocrinology and diabetes.
For Sponsorship and Exhibition inquiries, please contact firstname.lastname@example.org
Emirates Diabetes & Endocrine Congress (EDEC) is organized by Emirates Diabetes Society. EDEC is the region's premier platform to update attendees on the recent advances in the ever-changing field of diabetes and endocrine diseases.